263 related articles for article (PubMed ID: 2523817)
1. Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity.
van Binsbergen J; Slotboom AJ; Aarsman AJ; de Haas GH
FEBS Lett; 1989 Apr; 247(2):293-7. PubMed ID: 2523817
[TBL] [Abstract][Full Text] [Related]
2. 'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity.
Märki F; Pfeilschifter J; Rink H; Wiesenberg I
FEBS Lett; 1990 May; 264(2):171-5. PubMed ID: 2141575
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.
Davidson FF; Dennis EA; Powell M; Glenney JR
J Biol Chem; 1987 Feb; 262(4):1698-705. PubMed ID: 2948959
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of phospholipase A2 by protein I.
Khanna NC; Hee-Chong M; Severson DL; Tokuda M; Chong SM; Waisman DM
Biochem Biophys Res Commun; 1986 Sep; 139(2):455-60. PubMed ID: 2945554
[TBL] [Abstract][Full Text] [Related]
5. Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent.
Aarsman AJ; Mynbeek G; van den Bosch H; Rothhut B; Prieur B; Comera C; Jordan L; Russo-Marie F
FEBS Lett; 1987 Jul; 219(1):176-80. PubMed ID: 2954856
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of proteolytic fragments of lipocortin I that inhibit phospholipase A2.
Huang KS; McGray P; Mattaliano RJ; Burne C; Chow EP; Sinclair LK; Pepinsky RB
J Biol Chem; 1987 Jun; 262(16):7639-45. PubMed ID: 2953722
[TBL] [Abstract][Full Text] [Related]
7. Characterization of lipocortin I and an immunologically unrelated 33-kDa protein as epidermal growth factor receptor/kinase substrates and phospholipase A2 inhibitors.
Haigler HT; Schlaepfer DD; Burgess WH
J Biol Chem; 1987 May; 262(14):6921-30. PubMed ID: 3032981
[TBL] [Abstract][Full Text] [Related]
8. Lipocortin I and lipocortin II inhibit phosphoinositide- and polyphosphoinositide-specific phospholipase C. The effect results from interaction with the substrates.
Machoczek K; Fischer M; Söling HD
FEBS Lett; 1989 Jul; 251(1-2):207-12. PubMed ID: 2546821
[TBL] [Abstract][Full Text] [Related]
9. Lipocortin-like anti-phospholipase A2 activity of endonexin.
Fauvel J; Salles JP; Roques V; Chap H; Rochat H; Douste-Blazy L
FEBS Lett; 1987 May; 216(1):45-50. PubMed ID: 2953628
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phospholipases by Met-Leu-Phe-Ile-Leu-Ile-Lys-Arg-Ser-Arg-His-Phe, C terminus of middle-sized tumor antigen.
Notsu Y; Namiuchi S; Hattori T; Matsuda K; Hirata F
Arch Biochem Biophys; 1985 Jan; 236(1):195-204. PubMed ID: 2857079
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of phospholipase A2 by different lipocortins.
Weber G; Ferber E
Biol Chem Hoppe Seyler; 1990 Aug; 371(8):725-31. PubMed ID: 2144971
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase A2 inhibitory activity in thymocytes of dexamethasone-treated mice--possible implication of lipocortins.
Errasfa M; Rothhut B; Russo-Marie F
Biochem Biophys Res Commun; 1989 Feb; 159(1):53-60. PubMed ID: 2522304
[TBL] [Abstract][Full Text] [Related]
13. Structural importance of the amino-terminal residue of pancreatic phospholipase A2.
van Scharrenburg GJ; Jansen EH; Egmond MR; de Haas GH; Slotboom AJ
Biochemistry; 1984 Dec; 23(25):6285-94. PubMed ID: 6441599
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of a 32-kDa phospholipase A2 inhibitory protein (lipocortin) from human peripheral blood mononuclear cells.
Rothhut B; Comera C; Prieur B; Errasfa M; Minassian G; Russo-Marie F
FEBS Lett; 1987 Jul; 219(1):169-75. PubMed ID: 2954855
[TBL] [Abstract][Full Text] [Related]
15. Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activities.
Hope WC; Patel BJ; Bolin DR
Agents Actions; 1991 Sep; 34(1-2):77-80. PubMed ID: 1793057
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of a mutant human platelet phospholipase A2 expressed in Escherichia coli. Cleavage of a fusion protein with cyanogen bromide.
Franken PA; Van den Berg L; Huang J; Gunyuzlu P; Lugtigheid RB; Verheij HM; De Haas GH
Eur J Biochem; 1992 Jan; 203(1-2):89-98. PubMed ID: 1730245
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: possible mechanism of action.
Facchiano A; Cordella-Miele E; Miele L; Mukherjee AB
Life Sci; 1991; 48(5):453-64. PubMed ID: 1992287
[TBL] [Abstract][Full Text] [Related]
18. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity.
Wallner BP; Mattaliano RJ; Hession C; Cate RL; Tizard R; Sinclair LK; Foeller C; Chow EP; Browing JL; Ramachandran KL
Nature; 1986 Mar 6-12; 320(6057):77-81. PubMed ID: 2936963
[TBL] [Abstract][Full Text] [Related]
19. Proteinaceous inhibitors of phospholipase A2 purified from inflammatory sites in rats.
Suwa Y; Kudo I; Imaizumi A; Okada M; Kamimura T; Suzuki Y; Chang HW; Hara S; Inoue K
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2395-9. PubMed ID: 2320562
[TBL] [Abstract][Full Text] [Related]
20. Binding and inhibition studies on lipocortins using phosphatidylcholine vesicles and phospholipase A2 from snake venom, pancreas, and a macrophage-like cell line.
Davidson FF; Lister MD; Dennis EA
J Biol Chem; 1990 Apr; 265(10):5602-9. PubMed ID: 2138608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
